Robert Briddell

2.1k total citations
38 papers, 1.7k citations indexed

About

Robert Briddell is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Robert Briddell has authored 38 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 12 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Robert Briddell's work include Hematopoietic Stem Cell Transplantation (16 papers), Platelet Disorders and Treatments (12 papers) and Glycosylation and Glycoproteins Research (6 papers). Robert Briddell is often cited by papers focused on Hematopoietic Stem Cell Transplantation (16 papers), Platelet Disorders and Treatments (12 papers) and Glycosylation and Glycoproteins Research (6 papers). Robert Briddell collaborates with scholars based in United States, Denmark and Belgium. Robert Briddell's co-authors include Ian McNiece, J Brandt, Robert S. Hoffman, E Bruno, Koen van Besien, Ryan Cooper, Edward F. Srour, Ronald Hoffman, E Bruno and IK McNiece and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Blood.

In The Last Decade

Robert Briddell

37 papers receiving 1.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert Briddell 931 526 376 347 329 38 1.7k
Steven C. Goldstein 1.2k 1.3× 647 1.2× 246 0.7× 620 1.8× 313 1.0× 84 2.0k
Αthanasios Fassas 656 0.7× 677 1.3× 419 1.1× 657 1.9× 838 2.5× 65 2.6k
Patricia A. Dinndorf 581 0.6× 285 0.5× 373 1.0× 253 0.7× 213 0.6× 36 1.8k
MR Loken 1.1k 1.2× 725 1.4× 493 1.3× 266 0.8× 353 1.1× 13 1.8k
Todd W. Kelley 426 0.5× 622 1.2× 707 1.9× 325 0.9× 443 1.3× 68 2.0k
Udo Holtick 546 0.6× 631 1.2× 337 0.9× 728 2.1× 322 1.0× 87 1.9k
ED Zanjani 1.1k 1.2× 483 0.9× 476 1.3× 191 0.6× 702 2.1× 75 2.0k
David C. Weksberg 597 0.6× 698 1.3× 491 1.3× 260 0.7× 187 0.6× 18 1.6k
Jun Ooi 1.2k 1.3× 302 0.6× 285 0.8× 450 1.3× 401 1.2× 91 1.8k
E Bruno 1.7k 1.8× 556 1.1× 991 2.6× 392 1.1× 858 2.6× 61 2.9k

Countries citing papers authored by Robert Briddell

Since Specialization
Citations

This map shows the geographic impact of Robert Briddell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Briddell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Briddell more than expected).

Fields of papers citing papers by Robert Briddell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Briddell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Briddell. The network helps show where Robert Briddell may publish in the future.

Co-authorship network of co-authors of Robert Briddell

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Briddell. A scholar is included among the top collaborators of Robert Briddell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Briddell. Robert Briddell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rajan, Rahul S., Tiansheng Li, Mohini Aras, et al.. (2006). Modulation of protein aggregation by polyethylene glycol conjugation: GCSF as a case study. Protein Science. 15(5). 1063–1075. 95 indexed citations
2.
Carnahan, Josette, Paul Wang, Richard Kendall, et al.. (2003). Epratuzumab, a Humanized Monoclonal Antibody Targeting CD22. Clinical Cancer Research. 9(10). 5 indexed citations
3.
McNiece, Ian & Robert Briddell. (2001). Ex vivo expansion of hematopoietic progenitor cells and mature cells. Experimental Hematology. 29(1). 3–11. 58 indexed citations
4.
Johnsen, Hans Erik, J.-L. Canon, Thierry Guillaume, et al.. (2000). Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients. Bone Marrow Transplantation. 25(3). 243–249. 31 indexed citations
5.
McNiece, IK, et al.. (1998). Minimization of CD34+ Cell Enumeration Variability Using the ProCOUNT Standardized Methodology. Journal of Hematotherapy. 7(6). 499–504. 15 indexed citations
6.
McNiece, Ian, et al.. (1997). Large-Scale Isolation of CD34+ Cells Using the Amgen Cell Selection Device Results in High Levels of Purity and Recovery. Journal of Hematotherapy. 6(1). 5–11. 52 indexed citations
7.
McNiece, Ian, Robert Briddell, Cynthia Hartley, Kevin M. Smith, & Robert G. Andrews. (1996). Stem cell factor enhances in vivo effects of granulocyte colony stimulating factor for stimulating mobilization of peripheral blood progenitor cells. Stem Cells. 11(S2). 36–41. 19 indexed citations
8.
Morstyn, George, John A. Glaspy, Elizabeth J. Shpall, et al.. (1994). Clinical Applications of Filgrastim and Stem Cell Factor In Vivo and In Vitro. Journal of Hematotherapy. 3(4). 353–355. 6 indexed citations
9.
McNiece, IK, et al.. (1994). The Role of Stem Cell Factor in Mobilization of Peripheral Blood Progenitor Cells. Leukemia & lymphoma. 15(5-6). 405–409. 11 indexed citations
10.
11.
McNiece, Ian, Robert Briddell, Cynthia Hartley, & Robert G. Andrews. (1993). The role of stem cell factor in mobilization of peripheral blood progenitor cells: Synergy with G‐CSF. Stem Cells. 11(S3). 83–88. 19 indexed citations
12.
Bruno, E, Robert Briddell, Ryan Cooper, J Brandt, & R Hoffman. (1992). Recombinant GM-CSF/IL-3 fusion protein: its effect on in vitro human megakaryocytopoiesis.. PubMed. 20(4). 494–9. 23 indexed citations
13.
14.
Srour, Edward F., J Brandt, Robert Briddell, et al.. (1991). Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis.. PubMed. 17(2). 287–95. 110 indexed citations
15.
Brandt, J, Edward F. Srour, Koen van Besien, Robert Briddell, & Robert S. Hoffman. (1990). Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow.. Journal of Clinical Investigation. 86(3). 932–941. 147 indexed citations
16.
Hoffman, Robert S., Robert Briddell, Koen van Besien, et al.. (1989). Acquired Cyclic Amegakaryocytic Thrombocytopenia Associated with an Immunoglobulin Blocking the Action of Granulocyte–Macrophage Colony-Stimulating Factor. New England Journal of Medicine. 321(2). 97–102. 37 indexed citations
17.
Briddell, Robert, et al.. (1989). Serum from patients with various thrombopoietic disorders alters terminal cytoplasmic maturation of human megakaryocytes in vitro. European Journal Of Haematology. 42(3). 293–297. 4 indexed citations
18.
19.
McGuire, Warren A., H H Yang, E Bruno, et al.. (1987). Treatment of Antibody-Mediated Pure Red-Cell Aplasia with High-Dose Intravenous Gamma Globulin. New England Journal of Medicine. 317(16). 1004–1008. 78 indexed citations
20.
Bruno, E, et al.. (1987). Effect of perturbation of specific folate receptors during in vitro erythropoiesis.. Journal of Clinical Investigation. 80(6). 1618–1623. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven C. Goldstein Breakdown of academic impact, for papers by Αthanasios Fassas Breakdown of academic impact, for papers by Patricia A. Dinndorf Breakdown of academic impact, for papers by MR Loken Breakdown of academic impact, for papers by Todd W. Kelley Breakdown of academic impact, for papers by Udo Holtick Breakdown of academic impact, for papers by ED Zanjani Breakdown of academic impact, for papers by David C. Weksberg Breakdown of academic impact, for papers by Jun Ooi Breakdown of academic impact, for papers by E Bruno
Rankless by CCL
2026